• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. LEMAITRE AORTIC OCCLUSION CATHETER; LEMAITRE OCCLUSION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. LEMAITRE AORTIC OCCLUSION CATHETER; LEMAITRE OCCLUSION CATHETER Back to Search Results
Catalog Number OLC1050
Medical Device Problem Code Burst Container or Vessel (1074)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/20/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
We have not yet received the complaint device for evaluation.Hence, we could not conclusively determine the root cause of the incident.Our review of the lot history records for this lot number did not find any discrepancies either in the manufacturing or packaging process that could be related to this incident.Further, we have not received any other complaints of a similar nature for devices from this lot number.Catheter was used in a cadaver in order to remove the liver, kidneys and pancreas for transplant.Device operated properly during pre-use check and during initial phase of the procedure.It is possible that the balloon ruptured due to calcification on the aortic walls.
 
Event or Problem Description
A (b)(6) cadaver was put into ecmo with nonmothermic reperfusion in order to remove the liver, kidney and pancreas for transplant.The aortic balloon was channeled through the left femoral artery and was inflated to 30 cc with 0.9% saline.Radial blood pressure drop was verified confirming the catheter was functioning properly.During the procedure, ecmo stopped and it went to an asystole in less that 2 minutes.Transplant coordinator then infused saline to a maximum dose of 50 cc without experiencing any resistance.Ecmo was activated again and resumes self-resuscitation.However, ecmo stopped again.So, the procedure was suspended and the balloon was removed from the patient's vessel.He observed that the balloon of this catheter had ruptured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEMAITRE AORTIC OCCLUSION CATHETER
Common Device Name
LEMAITRE OCCLUSION CATHETER
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
MDR Report Key9504109
Report Number1220948-2019-00170
Device Sequence Number2082637
Product Code MJN
UDI-Device Identifier00840663101658
UDI-Public00840663101658
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
K132022
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/28/2024
Device Catalogue NumberOLC1050
Device Lot Number2107-81
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/20/2019
Initial Report FDA Received Date12/20/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age46 YR
-
-